Analytical Development for Biologics
December 5 - 6, 2018 - San Diego MA USCBI
matthew.douglas@cbinet.com
Phone:+1-339-298-2144
Biologic Discovery • Bioprocess Optimization • CMC With the expanding number of biologics, including new modalities and biosimilars, understanding product quality and detailed macromolecular structural attributes has become more important than ever. Enabling early-stage product characterization has become increasingly important in supporting efficient selection of candidates, clones, as well as driving acceleration in all areas of analytical CMC areas of activity. CBI’s Analytical Development for Biologics conference is singularly focused on state of the art bioanalytics and how the field must evolve to keep pace with current and emerging therapies. Join your peers and colleagues to advance and streamline analytical development. IN THIS CONFERENCE YOU WILL... • Review the latest protein characterization methods and approaches to product comparability • Find out what your peers are doing to streamline analytical development as well as expedite their company’s product approvals • Hear case studies of challenging characterization studies and interactions with regulators